{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:41:08Z","timestamp":1794555668060,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Liver fibrosis is characterized by an excessive accumulation of extracellular matrix (ECM), primarily produced by activated hepatic stellate cells (HSCs). The activation of HSCs is influenced by paracrine signaling interactions among various liver cell types, but molecular mechanisms remain to be elucidated. Secretory Meteorin-like (Metrnl) can effectively ameliorate fulminant hepatitis. However, little is known about its role in liver fibrosis. In our study, we found that hepatic Metrnl mRNA transcripts and protein expression were significantly downregulated in patients and mouse models of hepatic fibrosis. Hepatocyte-specific and global knockout of Metrnl exacerbated CCl4-induced liver fibrosis. In contrast, the administration recombinant Metrnl or AAV-Metrnl overexpression markedly ameliorated CCl4-induced liver fibrosis in mice, suggesting a protective role for Metrnl. Mechanistically, hepatocyte-derived Metrnl not only influences the activation of HSCs through paracrine signaling but also modulates the release of the fibrogenic cytokine PDGFB via the transcription factor EGR1, thereby regulating PDGFB\/PDGFR\u03b2 signaling to affect HSC activation. Furthermore, Metrnl absence in hepatocytes and HSCs leads to the downregulation of the E3 ubiquitin ligase HECW2, inhibiting K48-linked ubiquitination of FN and preventing its proteasomal degradation, thus promoting FN secretion from HSCs. These effects contribute to ECM deposition and the activation of HSCs, ultimately exacerbating liver fibrosis. Collectively, our study reveals Metrnl as a novel regulator of liver fibrosis that mediates communication between hepatocytes and HSCs, indicating its potential as a therapeutic target for liver fibrosis. The identification of Metrnl as a critical player in the pathogenesis of hepatic fibrosis underscores the importance of understanding cellular crosstalk in the progression of liver disease.<\/jats:p>","DOI":"10.1038\/s41419-025-07734-6","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:50:04Z","timestamp":1747752604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cellular crosstalk mediated by Meteorin-like regulating hepatic stellate cell activation during hepatic fibrosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6579-6068","authenticated-orcid":false,"given":"Yuxia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-7377","authenticated-orcid":false,"given":"Lingyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-1615","authenticated-orcid":false,"given":"Tuanlao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4871-1771","authenticated-orcid":false,"given":"Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-2597","authenticated-orcid":false,"given":"Bing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"7734_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"key":"7734_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Asp Med. 2019;65:37\u201355.","journal-title":"Mol Asp Med"},{"key":"7734_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.32299","volume":"76","author":"Y Lin","year":"2022","unstructured":"Lin Y, Dong MQ, Liu ZM, Xu M, Huang ZH, Liu HJ, et al. A strategy of vascular-targeted therapy for liver fibrosis. Hepatology. 2022;76:660\u201375.","journal-title":"Hepatology"},{"key":"7734_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther. 2022;7:206\u201327.","journal-title":"Signal Transduct Target Ther"},{"key":"7734_CR5","first-page":"303","volume":"6","author":"R Weiskirchen","year":"2015","unstructured":"Weiskirchen R. Hepatoprotective and anti-fibrotic agents: it\u2019s time to take the next step. Front Pharm. 2015;6:303\u201347.","journal-title":"Front Pharm"},{"key":"7734_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655\u201369.","journal-title":"Gastroenterology"},{"key":"7734_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7734_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2741\/gressner","volume":"7","author":"AM Gressner","year":"2002","unstructured":"Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Frontiers Biosci. 2002;7:793\u2013807.","journal-title":"Frontiers Biosci"},{"key":"7734_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.31083\/j.rcm2203086","volume":"22","author":"S Huang","year":"2021","unstructured":"Huang S, Cao L, Cheng H, Li D, Li Y, Wu Z. The blooming intersection of subfatin and metabolic syndrome. Rev Cardiovasc Med. 2021;22:799\u2013805.","journal-title":"Rev Cardiovasc Med"},{"key":"7734_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/s41401-020-00529-9","volume":"41","author":"ZW Miao","year":"2020","unstructured":"Miao ZW, Hu WJ, Li ZY, Miao CY. Involvement of the secreted protein Metrnl in human diseases. Acta Pharmacol Sin. 2020;41:1525\u201330.","journal-title":"Acta Pharmacol Sin"},{"key":"7734_CR11","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2337\/db23-0173","volume":"72","author":"L Song","year":"2023","unstructured":"Song L, Chang X, Hu L, Liu L, Wang G, Huang Y, et al. Accelerating wound closure with metrnl in normal and diabetic mouse skin. Diabetes. 2023;72:1692\u2013706.","journal-title":"Diabetes"},{"key":"7734_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","volume":"157","author":"RR Rao","year":"2014","unstructured":"Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157:1279\u201391.","journal-title":"Cell"},{"key":"7734_CR13","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/febs.15301","volume":"287","author":"JO Lee","year":"2020","unstructured":"Lee JO, Byun WS, Kang MJ, Han JA, Moon J, Shin MJ, et al. The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKalpha2. FEBS J. 2020;287:2087\u2013104.","journal-title":"FEBS J"},{"key":"7734_CR14","first-page":"1","volume":"50","author":"TW Jung","year":"2018","unstructured":"Jung TW, Lee SH, Kim H-C, Bang JS, Abd El-Aty AM, Hac\u0131m\u00fcft\u00fco\u011flu A, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice. Experimental Mol Med. 2018;50:1\u201311.","journal-title":"Experimental Mol Med"},{"key":"7734_CR15","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.2337\/db15-0274","volume":"64","author":"ZY Li","year":"2015","unstructured":"Li ZY, Song J, Zheng SL, Fan MB, Guan YF, Qu Y, et al. Adipocyte Metrnl antagonizes insulin resistance through PPARg signaling. Diabetes. 2015;64:4011\u201322.","journal-title":"Diabetes"},{"key":"7734_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20201206","volume":"218","author":"C Ruperez","year":"2021","unstructured":"Ruperez C, Ferrer-Curriu G, Cervera-Barea A, Florit L, Guitart-Mampel M, Garrabou G, et al. Meteorin-like\/Meteorin-beta protects heart against cardiac dysfunction. J Exp Med. 2021;218:1\u201318.","journal-title":"J Exp Med"},{"key":"7734_CR17","doi-asserted-by":"publisher","first-page":"e924564","DOI":"10.12659\/MSM.924564","volume":"26","author":"L Xu","year":"2020","unstructured":"Xu L, Cai Y, Wang Y, Xu C. Meteorin-Like (METRNL) Attenuates myocardial ischemia\/reperfusion injury-induced cardiomyocytes apoptosis by alleviating endoplasmic reticulum stress via activation of AMPK-PAK2 signaling in H9C2 cells. Med Sci Monit. 2020;26:e924564\u201375.","journal-title":"Med Sci Monit"},{"key":"7734_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jare.2022.10.014","volume":"51","author":"QB Lu","year":"2022","unstructured":"Lu QB, Ding Y, Liu Y, Wang ZC, Wu YJ, Niu KM, et al. Metrnl ameliorates diabetic cardiomyopathy via inactivation of cGAS\/STING signaling dependent on LKB1\/AMPK\/ULK1-mediated autophagy. J Adv Res. 2022;51:161\u201379.","journal-title":"J Adv Res"},{"key":"7734_CR19","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41401-020-0368-8","volume":"41","author":"Q Qi","year":"2020","unstructured":"Qi Q, Hu WJ, Zheng SL, Zhang SL, Le YY, Li ZY, et al. Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride. Acta Pharmacol Sin. 2020;41:1568\u201375.","journal-title":"Acta Pharmacol Sin"},{"key":"7734_CR20","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/s41401-022-01049-4","volume":"44","author":"Y-n Du","year":"2023","unstructured":"Du Y-n, Teng J-m, Zhou T-h, Du B-y, Cai W. Meteorin-like protein overexpression ameliorates fulminant hepatitis in mice by inhibiting chemokine-dependent immune cell infiltration. Acta Pharmacol Sin. 2023;44:1404\u201315.","journal-title":"Acta Pharmacol Sin"},{"key":"7734_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/db22-0680","volume":"72","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Liu L, Jin B, Wu Y, Xu L, Chang X, et al. Metrnl alleviates lipid accumulation by modulating mitochondrial homeostasis in diabetic nephropathy. Diabetes. 2023;72:611\u201326.","journal-title":"Diabetes"},{"key":"7734_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.addr.2018.08.009","volume":"146","author":"JQ Coentro","year":"2019","unstructured":"Coentro JQ, Pugliese E, Hanley G, Raghunath M, Zeugolis DI. Current and upcoming therapies to modulate skin scarring and fibrosis. Adv Drug Deliv Rev. 2019;146:37\u201359.","journal-title":"Adv Drug Deliv Rev"},{"key":"7734_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","volume":"45","author":"P Czochra","year":"2006","unstructured":"Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. Journal Hepatol. 2006;45:419\u201328.","journal-title":"Journal Hepatol"},{"key":"7734_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/biom14070749","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J. TFTF: an R-based integrative tool for decoding human transcription factor\u2013target interactions. Biomolecules. 2024;14:749\u201364.","journal-title":"Biomolecules"},{"key":"7734_CR25","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms21051664","volume":"21","author":"E Havis","year":"2020","unstructured":"Havis E, Duprez D. EGR1 transcription factor is a multifaceted regulator of matrix production in tendons and other connective tissues. Int J Mol Sci. 2020;21:1664\u201389.","journal-title":"Int J Mol Sci"},{"key":"7734_CR26","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.1016\/j.jhepr.2023.100724","volume":"5","author":"Y Guo","year":"2023","unstructured":"Guo Y, Miao X, Sun X, Li L, Zhou A, Zhu X, et al. Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease. JHEP Rep. 2023;5:100724\u201339.","journal-title":"JHEP Rep"},{"key":"7734_CR27","doi-asserted-by":"publisher","first-page":"23060","DOI":"10.1074\/jbc.M604311200","volume":"281","author":"D Ray","year":"2006","unstructured":"Ray D, Osmundson EC, Kiyokawa H. Constitutive and UV-induced fibronectin degradation is a ubiquitination-dependent process controlled by beta-TrCP. J Biol Chem. 2006;281:23060\u20135.","journal-title":"J Biol Chem"},{"key":"7734_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1152\/ajprenal.00157.2002","volume":"285","author":"GA McDonald","year":"2003","unstructured":"McDonald GA, Sarkar P, Rennke H, Unemori E, Kalluri R. VP S. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am J Physiol Ren Physiol. 2003;285:59\u201367.","journal-title":"Am J Physiol Ren Physiol"},{"key":"7734_CR29","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/s41418-018-0090-y","volume":"25","author":"N El-Hachem","year":"2018","unstructured":"El-Hachem N, Habel N, Naiken T, Bzioueche H, Cheli Y, Beranger GE, et al. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells. Cell Death Differ. 2018;25:2010\u201322.","journal-title":"Cell Death Differ"},{"key":"7734_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. Journal Clin Investig. 2005;115:209\u201318.","journal-title":"Journal Clin Investig"},{"key":"7734_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.abn3027","volume":"376","author":"MR Reboll","year":"2022","unstructured":"Reboll MR, Klede S, Taft MH, Cai C-L, Field LJ, Lavine KJ, et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase. Science. 2022;376:1343\u20137.","journal-title":"Science"},{"key":"7734_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s42255-020-0184-y","volume":"2","author":"GS Baht","year":"2020","unstructured":"Baht GS, Bareja A, Lee DE, Rao RR, Huang R, Huebner JL, et al. Meteorin-like facilitates skeletal muscle repair through a Stat3\/IGF-1 mechanism. Nat Metab. 2020;2:278\u201389.","journal-title":"Nat Metab"},{"key":"7734_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","volume":"62","author":"BM Klinkhammer","year":"2018","unstructured":"Klinkhammer BM, Floege J, Boor P. PDGF in organ fibrosis. Mol Asp Med. 2018;62:44\u201362.","journal-title":"Mol Asp Med"},{"key":"7734_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler JHW, Gyorfi AH, Ramanujam M, Whitfield ML, Konigshoff M, Lafyatis R. Shared and distinct mechanisms of fibrosis. Nat Rev Rheumatol. 2019;15:705\u201330.","journal-title":"Nat Rev Rheumatol"},{"key":"7734_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","volume":"15","author":"JC Bonner","year":"2004","unstructured":"Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004;15:255\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7734_CR36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1139\/cjpp-2017-0768","volume":"96","author":"S Mekala","year":"2018","unstructured":"Mekala S, Tulimilli SV, Geesala R, Manupati K, Dhoke NR. Dasa A. Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor \u03b2 during hepatic injury activates hepatic stellate cells. Can J Physiol Pharm. 2018;96:728\u201341.","journal-title":"Can J Physiol Pharm"},{"key":"7734_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12964-018-0306-2","volume":"16","author":"BJ Lim","year":"2018","unstructured":"Lim BJ, Lee WK, Lee HW, Lee KS, Kim JK, Chang HY, et al. Selective deletion of hepatocyte platelet-derived growth factor receptor alpha and development of liver fibrosis in mice. Cell Commun Signal. 2018;16:93\u2013104.","journal-title":"Cell Commun Signal"},{"key":"7734_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.dld.2019.08.014","volume":"52","author":"C Chen","year":"2020","unstructured":"Chen C, Li X, Wang L. Thymosinbeta4 alleviates cholestatic liver fibrosis in mice through downregulating PDGF\/PDGFR and TGFbeta\/Smad pathways. Dig Liver Dis. 2020;52:324\u201330.","journal-title":"Dig Liver Dis"},{"key":"7734_CR39","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI41203","volume":"120","author":"S Cao","year":"2010","unstructured":"Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, et al. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF\/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010;120:2379\u201394.","journal-title":"J Clin Invest"},{"key":"7734_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","volume":"63","author":"P Kocabayoglu","year":"2015","unstructured":"Kocabayoglu P, Lade A, Lee YA, Dragomir AC, Sun X, Fiel MI, et al. beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J Hepatol. 2015;63:141\u20137.","journal-title":"J Hepatol"},{"key":"7734_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5009\/gnl15566","volume":"11","author":"TZ Li","year":"2017","unstructured":"Li TZ, Kim SM, Hur W, Choi JE, Kim J-H, Hong SW, et al. Elk-3 contributes to the progression of liver fibrosis by regulating the epithelial-mesenchymal transition. Gut Liver. 2017;11:102\u201311.","journal-title":"Gut Liver"},{"key":"7734_CR42","doi-asserted-by":"publisher","first-page":"155380","DOI":"10.1016\/j.metabol.2022.155380","volume":"140","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang P, Yu Y, Huang E, Yao Y, Guo D, et al. Hepatocyte Ninjurin2 promotes hepatic stellate cell activation and liver fibrosis through the IGF1R\/EGR1\/PDGF-BB signaling pathway. Metabolism. 2023;140:155380\u201396.","journal-title":"Metabolism"},{"key":"7734_CR43","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/ATVBAHA.108.181081","volume":"29","author":"HY Chiang","year":"2009","unstructured":"Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 2009;29:1074\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7734_CR44","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1091\/mbc.e02-01-0048","volume":"13","author":"J Sottile","year":"2002","unstructured":"Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell. 2002;13:3546\u201359.","journal-title":"Mol Biol Cell"},{"key":"7734_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jhep.2014.06.010","volume":"62","author":"E Altrock","year":"2015","unstructured":"Altrock E, Sens C, Wuerfel C, Vasel M, Kawelke N, Dooley S, et al. Inhibition of fibronectin deposition improves experimental liver fibrosis. J Hepatol. 2015;62:625\u201333.","journal-title":"J Hepatol"},{"key":"7734_CR46","doi-asserted-by":"publisher","first-page":"23430","DOI":"10.1074\/jbc.M103467200","volume":"276","author":"BR Tomasini-Johansson","year":"2001","unstructured":"Tomasini-Johansson BR, Kaufman NR, Ensenberger MG, Ozeri V, Hanski E, Mosher DF. A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J Biol Chem. 2001;276:23430\u20139.","journal-title":"J Biol Chem"},{"key":"7734_CR47","doi-asserted-by":"publisher","first-page":"C1265","DOI":"10.1152\/ajpcell.00341.2009","volume":"298","author":"F Shi","year":"2010","unstructured":"Shi F, Harman J, Fujiwara K, Sottile J. Collagen I matrix turnover is regulated by fibronectin polymerization. Am J Physiol Cell Physiol. 2010;298:C1265\u201375.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7734_CR48","doi-asserted-by":"publisher","first-page":"18871","DOI":"10.1074\/jbc.M410762200","volume":"280","author":"SL Dallas","year":"2005","unstructured":"Dallas SL, Sivakumar P, Jones CJ, Chen Q, Peters DM, Mosher DF, et al. Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J Biol Chem. 2005;280:18871\u201380.","journal-title":"J Biol Chem"},{"key":"7734_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1359-6101(99)00010-6","volume":"10","author":"J Saharinen","year":"1999","unstructured":"Saharinen J, Hyyti\u00e4inen M, Taipale J, Keski-Oja J. Latent transforming growth factor-beta binding proteins (LTBPs)\u2013structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev. 1999;10:99\u2013117.","journal-title":"Cytokine Growth Factor Rev"},{"key":"7734_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","volume":"47","author":"IB Robertson","year":"2015","unstructured":"Robertson IB, Horiguchi M, Zilberberg L, Dabovic B, Hadjiolova K, Rifkin DB. Latent TGF-beta-binding proteins. Matrix Biol. 2015;47:44\u201353.","journal-title":"Matrix Biol"},{"key":"7734_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/db19-0086","volume":"69","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Liu Z, Zhang S, Zhuang R, Liu H, Liu X, et al. RILP restricts insulin secretion through mediating lysosomal degradation of proinsulin. Diabetes. 2020;69:67\u201382.","journal-title":"Diabetes"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07734-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07734-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:05:23Z","timestamp":1747753523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07734-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7734"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07734-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experimental protocols were approved by the Ethics Committee of Guizhou Medical University (approval number: 2000013) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health). Mice (3\u20135 per cage) were randomly grouped and housed under standard laboratory conditions (12-h light\/dark cycle, lights on at 9:00 AM, temperature maintained at 24\u2009\u00b0C), with free access to diets and water.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"405"}}